In enzalutamide-resistant PCa, AR signaling was reactivated in various ways so that AR drove NAIP expression, decreasing the sensitivity of PCa cells to CD8 + cytotoxic cells (Ardiani et al., 2014). The gene discussed is AR; the disease is posterior cortical atrophy.